⌘K

Login Start Free

Home/Filings/4/0001846478-25-000007

4//SEC Filing

Gutwerg Ori 4

Accession 0001846478-25-000007

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:09 PM ET

Size

10.0 KB

Accession

0001846478-25-000007

Insider Transaction Report

Form 4

Period: 2025-03-05

ANI PHARMACEUTICALS INCANIP

SVP, GENERICS

Transactions

Exercise/Conversion
Common Stock
2025-03-05$31.49/sh+300$9,447→ 99,476 total
Sale
Common Stock
2025-03-05$60.03/sh−300$18,009→ 99,176 total
Sale
Common Stock
2025-03-05$60.00/sh−5,084$305,040→ 94,092 total
Exercise/Conversion
Stock Option (right to buy)
2025-03-05$31.49/sh−300$9,447→ 13,204 total
Exercise: $31.49Exp: 2031-02-15→ Common Stock (300 underlying)

Footnotes (2)

[F1]The shares were sold in multiple trades at prices ranging from $60.00 to $60.03. The price reported above reflects the weighted average sales price.
[F2]25% of the total options vested on each of February 15, 2022, February 15, 2023, February 15, 2024, and February 15, 2025.

Documents

1 file

4
wk-form4_1741381758.xmlPrimary
FORM 4

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001846478

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 4:09 PM ET
Size: 10.0 KB

View on SEC.gov